Mobile App

Google Play Apple Store
Advanced Treatments in PAH: A Case-Based Approach
AMA/ANCC/ACPE Activity
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Recent progress in pulmonary arterial hypertension (PAH) is based on new strategies for combination therapy and the escalation of treatments to improve the significant morbidity and mortality associated with this disease. This on-demand presentation is a case-based discussion on the importance of a proper workup to reach the correct diagnosis and monitoring patients to determine when and how to optimally alter their PAH therapy.
Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.





Ronald Oudiz, MD, FACP, FACC, FCCP Ronald Oudiz, MD, FACP, FACC, FCCP
Professor of Medicine
David Geffen School of Medicine at UCLA
Director, Liu Center for Pulmonary Hypertension
Lundquist Institute at Harbor-UCLA Medical Center
Torrance, CA  
Vijay Balasubramanian MD, MRCP (UK) Vijay Balasubramanian MD, MRCP (UK)
Clinical Professor of Medicine
Medical Director, Pulmonary Hypertension Program
UCSF Fresno
Fresno, CA

20

Supported by independent educational grants from United Therapeutics, Bayer U.S. and Actelion Pharmaceuticals U.S., Inc.,

A Janssen Pharmaceutical Company of Johnson & Johnson


Launch Date: August 25, 2022

Release Date: August 10, 2022

Expiration Date: July 31, 2023

July 31, 2023
Mini Module
7445
TalkingPAH2022_WebBanner(1150px).gif
Pulmonology